These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Integrated morbidity mapping of lymphatic filariasis and podoconiosis cases in 20 co-endemic districts of Ethiopia. Kebede B; Martindale S; Mengistu B; Kebede B; Mengiste A; H/Kiros F; Tamiru A; Davey G; Kelly-Hope LA; Mackenzie CD PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006491. PubMed ID: 29965963 [TBL] [Abstract][Full Text] [Related]
6. How Thailand eliminated lymphatic filariasis as a public health problem. Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143 [TBL] [Abstract][Full Text] [Related]
7. The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania. Gass KM; Sime H; Mwingira UJ; Nshala A; Chikawe M; Pelletreau S; Barbre KA; Deming MS; Rebollo MP PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005944. PubMed ID: 28976981 [TBL] [Abstract][Full Text] [Related]
8. Mapping of lymphatic filariasis in loiasis areas: A new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon. Wanji S; Esum ME; Njouendou AJ; Mbeng AA; Chounna Ndongmo PW; Abong RA; Fru J; Fombad FF; Nchanji GT; Ngongeh G; Ngandjui NV; Enyong PI; Storey H; Curtis KC; Fischer K; Fauver JR; Lew D; Goss CW; Fischer PU PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007192. PubMed ID: 30849120 [TBL] [Abstract][Full Text] [Related]
9. Cross-Reactivity of Filariais ICT Cards in Areas of Contrasting Endemicity of Loa loa and Mansonella perstans in Cameroon: Implications for Shrinking of the Lymphatic Filariasis Map in the Central African Region. Wanji S; Amvongo-Adjia N; Koudou B; Njouendou AJ; Chounna Ndongmo PW; Kengne-Ouafo JA; Datchoua-Poutcheu FR; Fovennso BA; Tayong DB; Fombad FF; Fischer PU; Enyong PI; Bockarie M PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004184. PubMed ID: 26544042 [TBL] [Abstract][Full Text] [Related]
10. Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya. Njenga SM; Kanyi HM; Mutungi FM; Okoyo C; Matendechero HS; Pullan RL; Halliday KE; Brooker SJ; Wamae CN; Onsongo JK; Won KY Parasit Vectors; 2017 Feb; 10(1):99. PubMed ID: 28228160 [TBL] [Abstract][Full Text] [Related]
11. Mapping the baseline prevalence of lymphatic filariasis across Nigeria. Eneanya OA; Fronterre C; Anagbogu I; Okoronkwo C; Garske T; Cano J; Donnelly CA Parasit Vectors; 2019 Sep; 12(1):440. PubMed ID: 31522689 [TBL] [Abstract][Full Text] [Related]
12. Mapping and Modelling the Geographical Distribution and Environmental Limits of Podoconiosis in Ethiopia. Deribe K; Cano J; Newport MJ; Golding N; Pullan RL; Sime H; Gebretsadik A; Assefa A; Kebede A; Hailu A; Rebollo MP; Shafi O; Bockarie MJ; Aseffa A; Hay SI; Reithinger R; Enquselassie F; Davey G; Brooker SJ PLoS Negl Trop Dis; 2015; 9(7):e0003946. PubMed ID: 26222887 [TBL] [Abstract][Full Text] [Related]
13. Lymphatic filariasis mapping by immunochromatographic test cards and baseline microfilaria survey prior to mass drug administration in Sierra Leone. Koroma JB; Bangura MM; Hodges MH; Bah MS; Zhang Y; Bockarie MJ Parasit Vectors; 2012 Jan; 5():10. PubMed ID: 22236419 [TBL] [Abstract][Full Text] [Related]
14. Impact of mass drug administration for elimination of lymphatic filariasis in Nepal. Ojha CR; Joshi B; Kc KP; Dumre SP; Yogi KK; Bhatta B; Adhikari T; Crowley K; Marasini BR PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005788. PubMed ID: 28723904 [TBL] [Abstract][Full Text] [Related]
15. Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon. Beng AA; Esum ME; Deribe K; Njouendou AJ; Ndongmo PWC; Abong RA; Fru J; Fombad FF; Nchanji GT; Amambo G; Gandjui NTV; Biholong B; Nko'Ayissi G; Mbia P; Akame J; Enyong PI; Reid SD; Tougoue JJ; Zhang Y; Wanji S BMC Infect Dis; 2020 Apr; 20(1):284. PubMed ID: 32299374 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar. Dickson BFR; Graves PM; Aye NN; Nwe TW; Wai T; Win SS; Shwe M; Douglass J; Wood P; Wangdi K; McBride WJ Parasit Vectors; 2021 Jan; 14(1):72. PubMed ID: 33482891 [TBL] [Abstract][Full Text] [Related]
17. Developing the first national database and map of lymphatic filariasis clinical cases in Bangladesh: Another step closer to the elimination goals. Karim MJ; Haq R; Mableson HE; Sultan Mahmood ASM; Rahman M; Chowdhury SM; Rahman AKMF; Hafiz I; Betts H; Mackenzie C; Taylor MJ; Kelly-Hope LA PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007542. PubMed ID: 31306409 [TBL] [Abstract][Full Text] [Related]
18. Assessment of microfilaremia in 'hotspots' of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance. Mehta PK; Maharjan M PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011932. PubMed ID: 38295107 [TBL] [Abstract][Full Text] [Related]
19. The impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administration. de Souza DK; Ansumana R; Sessay S; Conteh A; Koudou B; Rebollo MP; Koroma J; Boakye DA; Bockarie MJ Parasit Vectors; 2015 Sep; 8():488. PubMed ID: 26399968 [TBL] [Abstract][Full Text] [Related]
20. Lymphatic filariasis in western Ethiopia with special emphasis on prevalence of Wuchereria bancrofti antigenaemia in and around onchocerciasis endemic areas. Shiferaw W; Kebede T; Graves PM; Golasa L; Gebre T; Mosher AW; Tadesse A; Sime H; Lambiyo T; Panicker KN; Richards FO; Hailu A Trans R Soc Trop Med Hyg; 2012 Feb; 106(2):117-27. PubMed ID: 22154976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]